Series date: 
01/01/2024 - 7:00am to 12/31/2024 - 8:00am

COURSE DIRECTOR
Timothy D. Lyon, M.D.

DESCRIPTION
Urology Grand Rounds, an innovative and dynamic program aimed at keeping Mayo Urology Consultants, Residents, and Advanced Practice Providers abreast of the latest advancements in the field. This course is meticulously designed to cover a comprehensive range of topics including localized and advanced prostate cancer, sexual dysfunction, bladder and renal cancer, urinary incontinence, genito-urinary trauma, and benign prostate hypertrophy. Participants will benefit from case-based management approach, which provides a platform for providers to engage in in-depth discussions on complex cases, fostering a collaborative environment for enhancing patient care and outcomes. Additionally, Morbidity and Mortality sessions are integral to the program, focusing on the systematic review of patient events and the quality of medical and surgical decision-making. This course is intended to be an engaging and educational experience that will expand expertise and knowledge in the urology specialty.

TARGET AUDIENCE
This course is intended primarily for Department of Urology, Department of Surgery, Department of Radiation Oncology: Residents/Fellows, physicians, PAs, ARNPs.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Acquire basic scientific and clinical knowledge covering the full spectrum of genitourinary disorders.
  • Utilize information technology to update treatment protocols according to patient preferences for specific genitourinary diseases. 
  • Demonstrate the ability to effectively communicate complex urologic conditions and their management options to colleagues and patients for enhanced collaborative care and informed decision-making. 
  • Evaluate current urologic patient care practices (patient outcomes) by critically examining current practice patterns and patient outcomes to identify opportunities for improvement with assimilation of current scientific evidence.
  • Construct individualized treatment plans based on patient-specific information for genitourinary diseases. 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA

Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 


ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
Timothy D. Lyon, M.D. - Intellectual Property: Intelligent Scopes Corp; Honoraria: UroGen Pharma, Inc., ImmunityBio, Emerging Therapy Solutions, Inc., Protara Therapeutics, Bristol-Myers Squibb Pharmaceutical

Raymond W. Pak, M.D., M.B.A. - Honoraria: Ambu, Inc., Ethicon Endo-Surgery, Inc. 

All relevant financial relationships listed for these individuals have been mitigated.

No relevant financial relationship(s) with ineligible companies:
Kathryn S. Cardona, APRN
Eric C. Robinson, P.A.-C.
Kevin M. Haenszel (Coordinator)
Lonnie R. Roller (Coordinator)
Nancy D. Stork (Coordinator)
Julie A. Thompson (Coordinator) (inactive 6.28.24)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

CE Broker Code: 24R00840

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Kevin Haenszel

Support location: 
Florida

Sessions

Session Date
Metabolic Evalution of Kidney Stones and Case Based Management 10/07/2024 - 7:00am to 8:00am
VMS Presentation on Mortality and Morbidity 10/14/2024 - 7:00am to 8:00am
VMS Presentation and Case Based Management 10/21/2024 - 7:00am to 8:00am
Reconstruction 10/28/2024 - 7:00am to 8:00am
GU Radiology In-service Review Part II 11/04/2024 - 7:00am to 8:00am
Radiotherapeutic Strategies in the Management of Prostate Cancer and VMS Presentation 11/11/2024 - 7:00am to 8:00am
Mortality and Morbidity 11/18/2024 - 7:00am to 8:00am
Case Based Management 11/25/2024 - 7:00am to 8:00am
ICDI Update and Case Based Management 12/02/2024 - 7:00am to 8:00am
FUS Presentations 12/09/2024 - 7:00am to 8:00am

Pages